-
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing (CORRECTED)
Friday, August 2, 2024 - 2:06pm | 747Editor's note: This story has been updated to reflect the proper spelling and city headquarters of GeneDx. GeneDx Holdings Corp. (NASDAQ:WGS) has made the biggest gains on the Russell 2000 Index in 2024 as the biotechnology company moves toward more comprehensive genetic testing. The Stamford,...
-
23andMe Under Siege: Hacker Reportedly Steals Millions Of Profiles In Genetic Data Heist
Saturday, October 7, 2023 - 3:07pm | 485An unidentified hacker reportedly claims to have stolen personal genetic data from millions of 23andMe Holding Co. (NASDAQ: ME) customer accounts, sparking concerns over privacy and security. The stolen data, a treasure trove of sensitive information including email addresses, photos...
-
Burning Rock Narrows Losses With Drug Research As New Driver
Thursday, June 8, 2023 - 12:55pm | 1122Key Takeaways: Burning Rock’s net loss narrowed 29% to 185 million yuan in the first quarter from the same period a year earlier, helped by lower R&D and sales expenses Revenues from R&D services for drug companies more than doubled, becoming the company’s latest growth engine...
-
Foundation Medicine Set For 'Material Upside,' Cowen Says In Bullish Initiation
Thursday, February 15, 2018 - 5:56pm | 430Foundation Medicine Inc (NASDAQ: FMI), a manufacturer of genomic analysis diagnostics for solid and circulating cancer, is uniquely positioned in comprehensive cancer profiling, a Cowen analyst said. The Analyst Cowen analyst Doug Schenkel initiated coverage of Foundation Medicine...